HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 260

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  


 
ORIGINAL ARTICLE Table of Contents   
Year : 2010  |  Volume : 35  |  Issue : 1  |  Page : 14-18
Use of 'Mishri' A smokeless form of tobacco during pregnancy and its perinatal outcome


1 Director of Research, KIMS University, Karad, India
2 Associate Professor, Department of PSM, RCSM GMC, Kolhapur, India
3 Ex-Professor, Department of Obstetrics/Gynecology BJMC, Pune, India
4 Deputy Director (PDE) DHS, Mumbai, India
5 Ex.Lecturer, Department of PSM, BJMC Pune, India

Correspondence Address:
Asha Pratinidhi
Krishna Institute of Medical Sciences University, Karad Staff Quarters B4, Karad, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0970-0218.62547

Rights and Permissions

Background: Use of 'Mishri' (Tobacco containing teeth cleaning powder) is common in the central and southern part of India. Objectives: To study the effects of Mishri use on the fetus during pregnancy and the perinatal outcome, and stopping its use. Materials and Methods: All apparently healthy pregnant women were enrolled at 20 weeks of gestation from rural Maharashtra, India. Information related to use and giving up of Mishri, previous obstetrical history, current pregnancy, delivery and outcome during the perinatal period were recorded. Appropriate tests of significance were applied. Results: Out of 705 enrolled pregnant women, 218 (30.9%) were using Mishri. The proportion of women with complications during the previous perinatal period, complaints and complications during the current pregnancy/delivery and the number of stillbirths were significantly more among Mishri users. A relative risk of abnormal delivery was 2.7 for the users. In spite of counseling, 153 women never stopped the use of Mishri and gave birth to babies weighing on an average 169.9 gm less (statistically significant) than babies born from the group that never used it. Babies of 28.8% who stopped/reduced consumption of Mishri were significantly benefited. Conclusions: The improvement seen in babies born to 28.8% mothers who stopped/reduced consumption of Mishri by 32 weeks during the current pregnancy is of paramount importance in the developing world for primary prevention of low birth weight.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4974    
    Printed143    
    Emailed0    
    PDF Downloaded394    
    Comments [Add]    
    Cited by others 12    

Recommend this journal

 

  Sitemap | What's New | Feedback | Copyright and Disclaimer
  2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007